Takaaki Matsuoka

Specialization: Aesthetic Doctor
23 years of experience
Workplace: Japan, Japan, Omotesando HELENE CLINIC
- Specialist at the clinic focused on regenerative medicine, anesthesiology, and medical management.
- Opened Omotesando Helene Clinic in 2013 and began systemic stem cell administration.
- Clinic materials state he was the first person to receive Stem Cell IV Therapy under the Regenerative Medicine Act.
Dr. Takaaki Matsuoka is the founder of Omotesando Helene Clinic in Tokyo. He was the first person to receive stem cell IV therapy under the Regenerative Medicine Act. Dr. Matsuoka holds a PhD in stem cell research and is a Diplomate of the American Board of Regenerative Medicine (DABRM).
- Performs systemic stem cell administration and regenerative plastic surgery.
- Completed 3,000 stem cell-based plastic surgeries.
- Is a lifetime member of the Harvard Medical School PGA.
- Was the Vice President of the Shobikai Medical Corporation.

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Dr. Takaaki Matsuoka specializes in regenerative medicine and stem cell therapy. He founded the Omotesando Helene Clinic in 2013. Dr. Matsuoka was the first person to receive Stem Cell IV Therapy under Japan’s Regenerative Medicine Act. He also holds a PhD in Medicine focused on stem cell research.

Specialization and Regenerative Techniques

Dr. Matsuoka performs systemic stem cell administration and regenerative treatments. He uses Stem Cell IV Therapy according to the standards of the Regenerative Medicine Act. Additionally, Dr. Matsuoka performs stem cell–based plastic surgery. Clinic records indicate he has performed over 3,000 stem cell plastic surgeries.

Dr. Matsuoka integrates his background in anesthesiology with medical management. His work in regenerative therapy began after he was diagnosed with thyroid cancer in 2011. After surgery, he used stem cell therapies to recover. This personal experience led him to start systemic stem cell administration for patients in 2013.

Work Experience

2003–2004 – Keio University Hospital, Department of Anesthesiology
2004 – Keiyukai Hospital, Department of Anesthesiology
2005 – Physician, Shobikai Medical Corporation
2009 – Vice President, Medical Corporation Shobikai
2013 – Founder, Omotesando Helene Clinic
2017 – Advisor

Education and Training

2003 – Keio University School of Medicine, Department of Anesthesiology (Graduated)
Peking University – Executive MBA
Doctor of Medicine, PhD in Medicine (Stem Cell Research)

Professional Memberships and Certifications

Diplomate of American Board of Regenerative Medicine (DABRM)
Lifetime Member of Harvard Medical School PGA

Awards and Recognition

In 2025, MEDTECH Outlook APAC recognized the clinic team as a Top Regenerative Medicine Solution Provider in APAC. This award highlights the clinic’s role in providing stem cell solutions in the Asia–Pacific region. Dr. Matsuoka leads the medical team at the Omotesando location in Tokyo.